TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
24,339,897
|
21,210,834
|
18,707,753 |
| Financial expenses |
13,594
|
24,994
|
158,115 |
| Earnings before taxes |
3,281,050
|
3,804,263
|
3,518,688 |
| EBITDA |
4,329,971
|
4,842,299
|
4,724,544 |
| Total assets |
33,036,947
|
31,479,494
|
28,873,657 |
| Current assets |
24,433,468
|
22,514,652
|
20,234,043 |
| Current liabilities |
3,097,664
|
2,967,038
|
2,913,285 |
| Equity capital |
28,549,563
|
26,912,705
|
24,533,041 |
| - share capital |
895
|
892
|
894 |
| Employees (average) |
10,587
|
9,734
|
8,336 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.4%
|
85.5%
|
85.0% |
| Turnover per employee |
2,299
|
2,179
|
2,244 |
| Profit as a percentage of turnover |
13.5%
|
17.9%
|
18.8% |
| Return on assets (ROA) |
10.0%
|
12.2%
|
12.7% |
| Current ratio |
788.8%
|
758.8%
|
694.5% |
| Return on equity (ROE) |
11.5%
|
14.1%
|
14.3% |
| Change turnover |
3,019,833
|
4,018,421
|
1,245,650 |
| Change turnover % |
14%
|
23%
|
7% |
| Chg. No. of employees |
853
|
1,398
|
195 |
| Chg. No. of employees % |
9%
|
17%
|
2% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.